Does coronary artery stenting for acute myocardial infarction improve left ventricular overloading at the chronic

Toru Nakayama1, Masahiro Nomura, Hiroyuki Fujinaga

  • 1Department of Internal Medicine, Kochi Red Cross Hospital, University of Tokushima, Tokushima, Japan.

Japanese Heart Journal
|April 20, 2004
PubMed

Insights

Coronary artery stenting, following acute myocardial infarction (AMI), reduces cardiac overloading and left ventricular remodeling compared to balloon angioplasty alone. Stenting improves myocardial blood flow and cardiac function post-AMI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Nuclear Cardiology

Background:

  • Coronary artery stenting is recognized for its benefits in improving cardiac function after acute myocardial infarction (AMI).
  • Evaluating the impact of stenting versus balloon angioplasty on cardiac remodeling and microcirculation is crucial for optimizing patient outcomes.

Purpose of the Study:

  • To assess the efficacy of coronary artery stenting in mitigating cardiac overloading and left ventricular remodeling in AMI patients.
  • To compare the effects of stenting versus percutaneous transluminal coronary angioplasty (POBA) alone on myocardial perfusion and cardiac biomarkers.

Main Methods:

  • 110 patients with AMI treated with direct angioplasty were divided into stenting (S group, 54 patients) and POBA alone (P group, 56 patients) groups.
  • (99m)Tc-tetrofosmin myocardial scintigraphy was used to calculate extent scores, reflecting decreased myocardial blood flow.
  • Levels of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), along with left ventricular end-diastolic volume index, were measured.

Main Results:

  • Patients in the stenting group (S) showed lower ANP and BNP levels at 1 and 3 months post-reperfusion compared to the POBA group (P).
  • Left ventricular end-diastolic volume index was significantly larger in the P group than the S group 3 months after reperfusion.
  • The extent/defect ratio, indicative of microcirculation disorders, was significantly lower in the P group (2.8 +/- 0.2) than the S group (3.5 +/- 0.3).

Conclusions:

  • Coronary artery stenting is more effective than POBA alone in reducing cardiac overloading and left ventricular remodeling after AMI.
  • Stenting likely preserves myocardial blood flow around the infarct zone, contributing to better long-term cardiac function.
  • These findings support stenting as a preferred strategy for managing AMI to prevent adverse cardiac remodeling.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...